Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Athena Countouriotis currently holds 49,303 shares of BIOMARIN PHARMACEUTICAL INC (BMRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Athena Countouriotis has been a net seller of BMRN stock. They have purchased $1.2M and sold $8.4M worth of shares.
Athena Countouriotis's most recent insider trade was on Jun 11, 2024, when they sold 49,303 shares at $0.00 per share.
Athena Countouriotis serves as Executive at BIOMARIN PHARMACEUTICAL INC (BMRN). They have executed 40 insider transactions totaling $9.6M over their tenure at the company.
Athena Countouriotis holds the position of Executive at BIOMARIN PHARMACEUTICAL INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Athena Countouriotis has shown a selling trading pattern, with $1.2M in total purchases and $8.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Athena Countouriotis was on Aug 17, 2022, when they sold $8.4M worth of TPTX shares. This transaction involved 110,959 shares at $76.00 per share.
Athena Countouriotis currently owns 49,303 shares of BIOMARIN PHARMACEUTICAL INC (BMRN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Athena Countouriotis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Athena Countouriotis has 40 Form 4 filings on record as an insider at BIOMARIN PHARMACEUTICAL INC.
Set alerts for Athena Countouriotis and 40,000+ other insiders.